Roger Wang

Roger Wang is a District Sales Executive specializing in oncology sales in Southern Taiwan, focusing on areas including breast, lung, gastrointestinal cancer, and hematology, as well as rare diseases such as multiple sclerosis. They have held various positions in pharmaceutical companies, including a Master Professional Sales Representative role at Pfizer, where they led sales initiatives for Ibrance and Talzenna from 2021 to 2024. Roger has a Master’s degree in Genome Sciences from National Yang Ming University, obtained between 2007 and 2009, and has demonstrated strengths in achieving sales targets and hospital listings through effective price negotiation and micro-marketing strategies.